$BCRX nytimes.com/2020/05/23/heal... “Given high mortality despite the use of remdesivir, it is clear that treatment with an antiviral drug alone is not likely to be sufficient,” they concluded. Remdesivir data released show they pushed it through, to make use of a drug that failed to treat hepatitis and then Ebola. Now reducing the recovery time on a small percentage of patients but showing no significant data to reduce death. Strong political and financial interest in promote Gilead’s drug, It’s a shame that there no brighter light and effort to push Galidesivir if it would produce better results and save lifes. More than the price share, I hope the trials bring positive results to impact the people in need of a treatment right now.